We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+17.1%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$14.1B
AUM Growth
+$1.4B
(+11%)
Cap. Flow
-$4.28B
Cap. Flow
% of AUM
-30.25%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
803
New
108
Increased
91
Reduced
295
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
|
+$61M |
| 2 |
RTX Corp
RTX
|
+$38.2M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$15.5M |
| 4 |
Delta Air Lines
DAL
|
+$14.5M |
| 5 |
SWT
Stanley Black & Decker, Inc.
SWT
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$578M |
| 2 |
AGN
Allergan plc
AGN
|
+$67M |
| 3 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$51.1M |
| 4 |
Alibaba
BABA
|
+$46.8M |
| 5 |
lululemon athletica
LULU
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.91% |
| 2 | Healthcare | 8.15% |
| 3 | Consumer Discretionary | 7.49% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Marathon Petroleum
MPC
$91.2B
| $26.8M | 0.19% |
715,734
-430,122
| -38% | -$13.8M |
|
102
Intuitive Surgical
ISRG
$127B
| $26.6M | 0.19% |
140,100
-19,374
| -12% | -$3.47M |
|
103
Boston Scientific
BSX
$68.3B
| $26.6M | 0.19% |
757,333
-389,033
| -34% | -$14M |
|
104
Royal Caribbean
RCL
$79.2B
| $26.5M | 0.19% |
527,777
-161,271
| -23% | -$7.3M |
|
105
Amgen
AMGN
$203B
| $26M | 0.18% |
110,210
-4,270
| -4% | -$974K |
|
106
PUT
iShares Russell 2000 ETF
IWM
$80.3B
| $25.8M | 0.18% |
+180,000
| New | +$23.6M |
|
|
ENR.PRA
107
DELISTED
Energizer Holdings, Inc. 7.50% Series A Mandatory Convertible Preferred Stock
ENR.PRA
| $25.4M | 0.18% |
264,455
-376
| -0.1% | -$33K |
|
108
Philip Morris
PM
$305B
| $25.3M | 0.18% |
361,184
-11,698
| -3% | -$853K |
|
109
CALL
Visa
V
$689B
| $25.1M | 0.18% |
+130,000
| New | +$23.7M |
|
110
Alcon
ALC
$33B
| $24.3M | 0.17% |
423,866
-102,228
| -19% | -$5.79M |
|
111
CALL
Alphabet (Google) Class A
GOOGL
$4T
| $24.2M | 0.17% |
+342,000
| New | +$23.1M |
|
112
Tesla
TSLA
$1.22T
| $24.2M | 0.17% |
336,480
-38,520
| -10% | -$2.08M |
|
|
113
Alibaba
BABA
$274B
| $24.2M | 0.17% |
112,094
-224,667
| -67% | -$46.8M |
|
114
Qualcomm
QCOM
$179B
| $23.9M | 0.17% |
261,767
-12,525
| -5% | -$1M |
|
|
AL
115
DELISTED
Air Lease Corp
AL
| $23.8M | 0.17% |
812,811
-283,407
| -26% | -$7.57M |
|
116
CALL
Bank of America
BAC
$436B
| $23.5M | 0.17% |
+990,500
| New | +$23.4M |
|
117
Marvell Technology
MRVL
$170B
| $23.1M | 0.16% |
657,555
+7,368
| +1% | +$216K |
|
|
118
CALL
iShares Russell 2000 ETF
IWM
$80.3B
| $23M | 0.16% |
+160,500
| New | +$21.1M |
|
|
NVO
119
Novo Nordisk
NVO
$221B
| $22.7M | 0.16% |
693,326
+192,318
| +38% | +$6.14M |
|
120
Agilent Technologies
A
$39B
| $22.4M | 0.16% |
253,538
-100,251
| -28% | -$8.21M |
|
121
Waste Management
WM
$95.7B
| $22.2M | 0.16% |
209,799
-16,758
| -7% | -$1.69M |
|
|
122
Delta Air Lines
DAL
$56.6B
| $22.1M | 0.16% |
787,380
+568,712
| +260% | +$14.5M |
|
123
Zoetis
ZTS
$32.3B
| $21.8M | 0.15% |
159,394
+99,020
| +164% | +$12.9M |
|
124
Target
TGT
$63.7B
| $21.7M | 0.15% |
181,171
-53,382
| -23% | -$6.09M |
|
|
WTRU
125
DELISTED
Essential Utilities, Inc.6.00% Tangible Equity Units
WTRU
| $21.6M | 0.15% |
382,467
-1,300
| -0.3% | -$73.6K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Calamos Advisors held 803 positions worth $14.1B, up 11% from $12.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Calamos Advisors withdrew a net $4.28B in Q2 2020, closing 98 positions and reducing 295 holdings. Its most notable exit was Allergan plc, an estimated $67M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Calamos Advisors opened a new position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $59.7M.
- Calamos Advisors's largest Q2 2020 buy was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A: 569,916 shares worth $59.7M.
- Calamos Advisors added most to RTX Corp in Q2 2020, an estimated $38.2M increase.
- Calamos Advisors's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $578M.
- Calamos Advisors fully exited Allergan plc in Q2 2020, selling an estimated $67M.
- Calamos Advisors's ten largest holdings make up 20% of its $14.1B portfolio in Q2 2020.
- Calamos Advisors opened 108 new positions and closed 98 in Q2 2020.
- Calamos Advisors's portfolio value rose 11% quarter-over-quarter to $14.1B.
Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.